Lower Molecular Weight PAHs Increase Lung Tumor Risk
Author Information
Author(s): Bauer Alison K., Romo Deedee, Friday Finnegan, Cho Kaila, Velmurugan Kalpana, Upham Brad L.
Primary Institution: University of Colorado Anschutz Medical Campus
Hypothesis
Lower molecular weight PAHs contribute to the promotion stage of cancer when combined with benzo[a]pyrene.
Conclusion
The study found that non-genotoxic lower molecular weight PAHs significantly increase the tumorigenicity of benzo[a]pyrene in a mouse model.
Supporting Evidence
- Lower molecular weight PAHs combined with benzo[a]pyrene significantly increased lung tumor promotion.
- Inflammatory markers were elevated in the treatment group exposed to the PAH mixture and benzo[a]pyrene.
- Gene expression changes indicated a pro-inflammatory response linked to tumor promotion.
Takeaway
Some chemicals in the air can make lung cancer worse when mixed together, especially when combined with a known harmful substance.
Methodology
The study used a two-stage initiation/promotion lung tumor model in female BALB/ByJ mice, exposing them to a mixture of lower molecular weight PAHs and benzo[a]pyrene.
Potential Biases
The study did not assess potential sex differences as it only used female mice.
Limitations
The study only examined one time point and used a higher dose for initial testing, which may not reflect lower environmental exposures.
Participant Demographics
Five-week-old female BALB/ByJ mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website